Ultragenyx Pharmaceutical... (RARE)
undefined
undefined%
At close: undefined
41.20
-0.72%
After-hours Jan 03, 2025, 04:07 PM EST

Ultragenyx Pharmaceutical Inc. Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for RARE stock have an median target of 81, with a low estimate of 46 and a high estimate of 127. The median target predicts an increase of 95.18% from the current stock price of 41.50.

Analyst Consensus: Buy
Target Low Average Median High
Price $46 $88.46 $81 $127
Change 10.84% 113.16% 95.18% 206.02%

AI Analyst Report

HC Wainwright & Co. has reaffirmed a Buy rating fo... Unlock content with Pro Subscription

Updated Dec 24, 2024

Rating Jul 24Aug 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 010120
Buy 233242
Hold 110000
Sell 000000
Strong Sell 000000
Total 3 5 3 3 6 2

Financial Forecast this Year

Revenue This Year
627.55M
from -
Increased by ∞B%
Revenue Next Year
851.30M
from 627.55M
Increased by 35.7%
EPS This Year
-5.26
from null
Increased by -∞B%
EPS Next Year
-3.4
from -5.26
Increased by 35.4%